Ken Fisher Neurocrine Biosciences Inc Transaction History

Fisher Asset Management, LLC

  • $271 Billion
  • Q3 2025

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 94,795 shares of NBIX stock, worth $13.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,795
Previous 87,540 8.29%
Holding current value
$13.7 Million
Previous $11 Million 20.95%
% of portfolio
0.0%
Previous 0.0%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$123.98 - $146.67 $899,474 - $1.06 Million
7,255 Added 8.29%
94,795 $13.3 Million
Q2 2025

Aug 13, 2025
SELL
$87.54 - $128.18 $675,546 - $989,165
-7,717 Reduced 8.1%
87,540 $11 Million
Q1 2025

May 14, 2025
BUY
$107.22 - $153.29 $338,064 - $483,323
3,153 Added 3.42%
95,257 $10.5 Million
Q4 2024

Feb 05, 2025
BUY
$111.62 - $139.44 $2.66 Million - $3.32 Million
23,834 Added 34.91%
92,104 $12.6 Million
Q3 2024

Nov 12, 2024
BUY
$114.58 - $153.15 $564,879 - $755,029
4,930 Added 7.78%
68,270 $7.86 Million
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $238,950 - $261,464
-1,826 Reduced 2.8%
63,340 $8.72 Million
Q1 2024

May 09, 2024
BUY
$130.4 - $143.74 $644,045 - $709,931
4,939 Added 8.2%
65,166 $8.99 Million
Q4 2023

Mar 05, 2024
BUY
$106.07 - $132.76 $27,153 - $33,986
256 Added 0.43%
60,227 $7.94 Million
Q4 2023

Feb 06, 2024
SELL
$106.07 - $132.76 $196,865 - $246,402
-1,856 Reduced 3.0%
59,971 $7.9 Million
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $16,829 - $20,960
-179 Reduced 0.29%
61,827 $6.96 Million
Q2 2023

Dec 12, 2023
BUY
$89.53 - $104.87 $16,025 - $18,771
179 Added 0.29%
62,006 $5.85 Million
Q2 2023

Aug 08, 2023
SELL
$89.53 - $104.87 $222,123 - $260,182
-2,481 Reduced 3.85%
62,006 $5.85 Million
Q1 2023

Dec 12, 2023
BUY
$94.11 - $123.02 $217,864 - $284,791
2,315 Added 3.74%
64,142 $6.49 Million
Q1 2023

May 01, 2023
BUY
$94.11 - $123.02 $20,610 - $26,941
219 Added 0.34%
64,487 $6.53 Million
Q4 2022

Feb 03, 2023
SELL
$106.72 - $127.06 $90,498 - $107,746
-848 Reduced 1.3%
64,268 $7.68 Million
Q3 2022

Nov 08, 2022
SELL
$92.03 - $107.81 $493,464 - $578,077
-5,362 Reduced 7.61%
65,116 $6.92 Million
Q2 2022

Aug 09, 2022
SELL
$75.79 - $100.07 $316,650 - $418,092
-4,178 Reduced 5.6%
70,478 $6.87 Million
Q1 2022

May 05, 2022
BUY
$72.45 - $94.81 $652 - $853
9 Added 0.01%
74,656 $7 Million
Q4 2021

Feb 02, 2022
BUY
$79.65 - $106.22 $434,331 - $579,217
5,453 Added 7.88%
74,647 $6.36 Million
Q3 2021

Oct 26, 2021
BUY
$86.18 - $99.03 $650,228 - $747,181
7,545 Added 12.24%
69,194 $6.64 Million
Q2 2021

Jul 27, 2021
BUY
$89.43 - $102.27 $310,590 - $355,183
3,473 Added 5.97%
61,649 $6 Million
Q1 2021

Apr 27, 2021
BUY
$87.57 - $119.4 $65,327 - $89,072
746 Added 1.3%
58,176 $5.66 Million
Q4 2020

Jan 29, 2021
SELL
$86.91 - $108.33 $155,655 - $194,019
-1,791 Reduced 3.02%
57,430 $5.51 Million
Q3 2020

Nov 10, 2020
SELL
$96.16 - $135.15 $385,216 - $541,410
-4,006 Reduced 6.34%
59,221 $5.7 Million
Q2 2020

Aug 07, 2020
SELL
$85.09 - $130.36 $114,020 - $174,682
-1,340 Reduced 2.08%
63,227 $7.71 Million
Q1 2020

Apr 28, 2020
SELL
$75.11 - $113.76 $165,842 - $251,182
-2,208 Reduced 3.31%
64,567 $5.59 Million
Q4 2019

Feb 12, 2020
SELL
$86.8 - $118.57 $542,673 - $741,299
-6,252 Reduced 8.56%
66,775 $7.18 Million
Q3 2019

Oct 29, 2019
SELL
$83.82 - $101.5 $116,761 - $141,389
-1,393 Reduced 1.87%
73,027 $6.58 Million
Q2 2019

Jul 30, 2019
BUY
$72.24 - $91.27 $3.41 Million - $4.31 Million
47,257 Added 173.98%
74,420 $6.28 Million
Q1 2019

Apr 22, 2019
SELL
$69.31 - $91.53 $33,060 - $43,659
-477 Reduced 1.73%
27,163 $2.39 Million
Q4 2018

Jan 25, 2019
SELL
$68.32 - $124.36 $34,638 - $63,050
-507 Reduced 1.8%
27,640 $1.97 Million
Q3 2018

Oct 24, 2018
SELL
$98.88 - $125.85 $315,921 - $402,090
-3,195 Reduced 10.19%
28,147 $3.46 Million
Q2 2018

Jul 09, 2018
BUY
$75.3 - $105.99 $1.94 Million - $2.72 Million
25,702 Added 455.71%
31,342 $3.08 Million
Q1 2018

Apr 19, 2018
BUY
$75.88 - $92.43 $46,666 - $56,844
615 Added 12.24%
5,640 $468,000
Q4 2017

Jan 24, 2018
SELL
$58.53 - $77.59 $1,638 - $2,172
-28 Reduced 0.55%
5,025 $390,000
Q3 2017

Oct 17, 2017
BUY
$47.97 - $61.28 $242,392 - $309,647
5,053
5,053 $310,000

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email